Creative Medical Technology Holdings, Inc. (CELZ)

Accolade Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	8	4	6	5	14	17
Market Cap Growth	31.75%	-36.61%	18.77%	-61.64%	-16.41%	2018.13%
Enterprise Value	1	-2	-6	-17	14	18
Last Close Price	3.08	2.31	4.61	3.81	22.10	139.00
PE Ratio	-	-	-	-	0.73	-
PS Ratio	1326.82	367.17	707.96	60.55	159.35	101.69
PB Ratio	1.17	0.64	0.62	0.34	1.37	-0.42
P/TBV Ratio	1.25	0.70	0.64	0.35	1.44	-
EV/Sales Ratio	238.50	-	-	-	163.74	107.06
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	-0.02
Asset Turnover	0.00	0.00	0.00	0.01	0.02	0.26
Inventory Turnover	1.09	1.00	0.43	2.71	-	-
Quick Ratio	23.57	18.13	26.89	5.54	10.21	0.00
Current Ratio	23.89	18.73	27.66	5.64	10.22	0.00
Return on Equity (ROE)	-79.85%	-65.85%	-40.34%	-77.78%	-	-
Return on Assets (ROA)	-49.02%	-41.30%	-23.49%	-42.05%	-32.60%	-111.61%
Return on Capital (ROIC)	-51.14%	-42.96%	-26.78%	-49.04%	-	-
Earnings Yield	-72.42%	-136.01%	-82.97%	-189.10%	137.39%	-217.15%
Buyback Yield / Dilution	-35.82%	-5.17%	-28.76%	-236.51%	-460.63%	-

Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q